PCSK9 Inhibitors and Infection-Related Adverse Events: A Pharmacovigilance Study Using the World Health Organization VigiBase.
Dahyun ParkSungho BeaJi-Hwan BaeHyesung LeeYoung June ChoeJu Young ShinHoon KimPublished in: Drugs - real world outcomes (2024)
In addition to the labelled respiratory infections, six infection-related symptoms in the gastrointestinal, urinary, and renal organs were identified. Our findings support the need for systematic surveillance of infections among PCSK9i users.